Ignite Creation Date:
2024-05-05 @ 11:26 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01339988
Status:
UNKNOWN
Last Update Posted:
2011-04-21
First Post:
2011-04-20
Brief Title:
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation TBI and Cyclophosphamide for Hematological Malignancies Hematocrit HCT
Sponsor:
Organization:
Tel-Aviv Sourasky Medical Center
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
10
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: